Prostaglandins and ulcer healing

Area of Science:

• Gastroenterology and Pharmacology
• Molecular Biology and Biochemistry

Background:

• Gastro-duodenal ulcer healing involves complex molecular mechanisms.
• The role of prostaglandins (PG) and their synthetic pathways (COX enzymes) in ulcer repair is under investigation.

Purpose of the Study:

• To elucidate the role of endogenous and exogenous prostaglandins in gastro-duodenal ulcer healing.
• To investigate the impact of various therapeutic agents (PGs, COX inhibitors, PPIs, growth factors, hormones) on ulcer healing by examining their effects on COX-2 expression and PGE(2) generation.

Main Methods:

• The study analyzes the effects of different agents on ulcer healing, focusing on cyclooxygenase (COX) enzyme activity and prostaglandin E2 (PGE(2)) levels in ulcerated mucosa.
• Investigated are exogenous prostaglandins, COX-1/COX-2 inhibitors, dexamethasone, proton pump inhibitors (PPIs), growth factors (EGF, TGF-α, HGF), and gut hormones (gastrin, CCK), as well as melatonin.

Main Results:

• Exogenous prostaglandins in high doses accelerate healing by enhancing COX-2 and PGE(2) in ulcers; low doses do not.
• COX inhibitors and dexamethasone delay healing by suppressing PG generation and altering COX-2 expression.
• PPIs and PGE analogs accelerate healing, partly by increasing COX-2 expression and PGE(2) generation in ulcerated mucosa.
• Growth factors, gastrin, CCK, and melatonin promote healing, mediated partly by increased COX-2 and PGE(2) release.

Conclusions:

• Endogenous prostaglandins, primarily from upregulated COX-2 at the ulcer margin, are critical for ulcer healing.
• Therapeutic acceleration of ulcer healing by exogenous PGs, PPIs, growth factors, gut hormones, and melatonin involves mechanisms that upregulate COX-2 and PGE(2) production.
• COX-1 and COX-2 inhibitors impede ulcer healing by reducing PG generation and paradoxically increasing COX-2 expression in the ulcer area.